Market will decide that, but for someone who's been in IHL since ~2c and seeing it literally go nowhere until the substantive development of the MedCann side and turning of IHL from a mouthguard meme company into an IP Creating MedCann entity with some of the best in the business in management, professional medical talent and direct equity partnership with Australia's largest distributor in CannVaLate and partnerships with US based AXIM Biotech....
Likely correct. On the revenue side I am simply hoping that they have continued to reduce costs and increase rev as they have done all year. Maybe the Air Liquide deal will yield some fruit. OC didnt give us anything yet, better to cut it off early if that is the direction the company wants to take rather than split our honestly meager funds towards Incannex and this stuff.
Pick whats most important and ride that train all the way.
IHL Price at posting:
8.3¢ Sentiment: Buy Disclosure: Held
